203 related articles for article (PubMed ID: 31316341)
1. Huntington's Disease Patient-Derived Astrocytes Display Electrophysiological Impairments and Reduced Neuronal Support.
Garcia VJ; Rushton DJ; Tom CM; Allen ND; Kemp PJ; Svendsen CN; Mattis VB
Front Neurosci; 2019; 13():669. PubMed ID: 31316341
[TBL] [Abstract][Full Text] [Related]
2. Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys.
Cho IK; Yang B; Forest C; Qian L; Chan AWS
PLoS One; 2019; 14(3):e0214156. PubMed ID: 30897183
[TBL] [Abstract][Full Text] [Related]
3. Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington's disease patient cells.
Juopperi TA; Kim WR; Chiang CH; Yu H; Margolis RL; Ross CA; Ming GL; Song H
Mol Brain; 2012 May; 5():17. PubMed ID: 22613578
[TBL] [Abstract][Full Text] [Related]
4. Human Huntington's Disease iPSC-Derived Cortical Neurons Display Altered Transcriptomics, Morphology, and Maturation.
Mehta SR; Tom CM; Wang Y; Bresee C; Rushton D; Mathkar PP; Tang J; Mattis VB
Cell Rep; 2018 Oct; 25(4):1081-1096.e6. PubMed ID: 30355486
[TBL] [Abstract][Full Text] [Related]
5. Dysfunctional Calcium and Glutamate Signaling in Striatal Astrocytes from Huntington's Disease Model Mice.
Jiang R; Diaz-Castro B; Looger LL; Khakh BS
J Neurosci; 2016 Mar; 36(12):3453-70. PubMed ID: 27013675
[TBL] [Abstract][Full Text] [Related]
6. Energy Metabolism and Mitochondrial Superoxide Anion Production in Pre-symptomatic Striatal Neurons Derived from Human-Induced Pluripotent Stem Cells Expressing Mutant Huntingtin.
Hamilton J; Brustovetsky T; Sridhar A; Pan Y; Cummins TR; Meyer JS; Brustovetsky N
Mol Neurobiol; 2020 Feb; 57(2):668-684. PubMed ID: 31435904
[TBL] [Abstract][Full Text] [Related]
7. Elucidating the role of the A2A adenosine receptor in neurodegeneration using neurons derived from Huntington's disease iPSCs.
Chiu FL; Lin JT; Chuang CY; Chien T; Chen CM; Chen KH; Hsiao HY; Lin YS; Chern Y; Kuo HC
Hum Mol Genet; 2015 Nov; 24(21):6066-79. PubMed ID: 26264576
[TBL] [Abstract][Full Text] [Related]
8. Mutant huntingtin reduction in astrocytes slows disease progression in the BACHD conditional Huntington's disease mouse model.
Wood TE; Barry J; Yang Z; Cepeda C; Levine MS; Gray M
Hum Mol Genet; 2019 Feb; 28(3):487-500. PubMed ID: 30312396
[TBL] [Abstract][Full Text] [Related]
9. Potassium channel dysfunction in neurons and astrocytes in Huntington's disease.
Zhang X; Wan JQ; Tong XP
CNS Neurosci Ther; 2018 Apr; 24(4):311-318. PubMed ID: 29377621
[TBL] [Abstract][Full Text] [Related]
10. Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient.
Chae JI; Kim DW; Lee N; Jeon YJ; Jeon I; Kwon J; Kim J; Soh Y; Lee DS; Seo KS; Choi NJ; Park BC; Kang SH; Ryu J; Oh SH; Shin DA; Lee DR; Do JT; Park IH; Daley GQ; Song J
Biochem J; 2012 Sep; 446(3):359-71. PubMed ID: 22694310
[TBL] [Abstract][Full Text] [Related]
11. A critical role of astrocyte-mediated nuclear factor-κB-dependent inflammation in Huntington's disease.
Hsiao HY; Chen YC; Chen HM; Tu PH; Chern Y
Hum Mol Genet; 2013 May; 22(9):1826-42. PubMed ID: 23372043
[TBL] [Abstract][Full Text] [Related]
12. Progerin-Induced Transcriptional Changes in Huntington's Disease Human Pluripotent Stem Cell-Derived Neurons.
Cohen-Carmon D; Sorek M; Lerner V; Divya MS; Nissim-Rafinia M; Yarom Y; Meshorer E
Mol Neurobiol; 2020 Mar; 57(3):1768-1777. PubMed ID: 31834602
[TBL] [Abstract][Full Text] [Related]
13. Huntington's disease iPSC models-using human patient cells to understand the pathology caused by expanded CAG repeats.
Kaye J; Reisine T; Finkbeiner S
Fac Rev; 2022; 11():16. PubMed ID: 35865413
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of soluble tumor necrosis factor is therapeutic in Huntington's disease.
Hsiao HY; Chiu FL; Chen CM; Wu YR; Chen HM; Chen YC; Kuo HC; Chern Y
Hum Mol Genet; 2014 Aug; 23(16):4328-44. PubMed ID: 24698979
[TBL] [Abstract][Full Text] [Related]
15. Expression of mutant N-terminal huntingtin fragment (htt552-100Q) in astrocytes suppresses the secretion of BDNF.
Wang L; Lin F; Wang J; Wu J; Han R; Zhu L; Difiglia M; Qin Z
Brain Res; 2012 Apr; 1449():69-82. PubMed ID: 22410294
[TBL] [Abstract][Full Text] [Related]
16. A Human Induced Pluripotent Stem Cell-Derived Isogenic Model of Huntington's Disease Based on Neuronal Cells Has Several Relevant Phenotypic Abnormalities.
Malankhanova T; Suldina L; Grigor'eva E; Medvedev S; Minina J; Morozova K; Kiseleva E; Zakian S; Malakhova A
J Pers Med; 2020 Nov; 10(4):. PubMed ID: 33182269
[TBL] [Abstract][Full Text] [Related]
17. Striatal spatial heterogeneity, clustering, and white matter association of GFAP
Brown TG; Thayer MN; VanTreeck JG; Zarate N; Hart DW; Heilbronner S; Gomez-Pastor R
Front Cell Neurosci; 2023; 17():1094503. PubMed ID: 37187609
[TBL] [Abstract][Full Text] [Related]
18. PolyQ length-dependent metabolic alterations and DNA damage drive human astrocyte dysfunction in Huntington's disease.
Lange J; Gillham O; Flower M; Ging H; Eaton S; Kapadia S; Neueder A; Duchen MR; Ferretti P; Tabrizi SJ
Prog Neurobiol; 2023 Jun; 225():102448. PubMed ID: 37023937
[TBL] [Abstract][Full Text] [Related]
19. PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington's disease (HD).
Ratovitski T; Arbez N; Stewart JC; Chighladze E; Ross CA
Cell Cycle; 2015; 14(11):1716-29. PubMed ID: 25927346
[TBL] [Abstract][Full Text] [Related]
20. Manifestation of Huntington's disease pathology in human induced pluripotent stem cell-derived neurons.
Nekrasov ED; Vigont VA; Klyushnikov SA; Lebedeva OS; Vassina EM; Bogomazova AN; Chestkov IV; Semashko TA; Kiseleva E; Suldina LA; Bobrovsky PA; Zimina OA; Ryazantseva MA; Skopin AY; Illarioshkin SN; Kaznacheyeva EV; Lagarkova MA; Kiselev SL
Mol Neurodegener; 2016 Apr; 11():27. PubMed ID: 27080129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
